FDA Clears Sentient’s Tixel for Treatment of Periorbital Wrinkles
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Clinical trial results showed improvements in neck appearance lasting up to six months following treatment.